The pharmacological management of erectile dysfunction
The inability to attain or maintain a penile erection sufficient for sexual intercourse is a common problem experienced by a third of men over the age of 40 years. Erectile dysfunction (ED) is a debilitating disease which can have profound psychological effects on personal relationships and the soci...
Saved in:
| Main Author: | Andre Marais |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AOSIS
2015-07-01
|
| Series: | South African Family Practice |
| Subjects: | |
| Online Access: | https://safpj.co.za/index.php/safpj/article/view/4298 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The pharmacological management of erectile dysfunction – Update 2016
by: André Marais
Published: (2016-08-01) -
PHOSPHODIESTERASE-5 INHIBITORS USE IN PATIENTS WITH ERECTILE DYSFUNCTION AND CARDIOVASCULAR DISEASE IN CLINICAL PRACTICE
by: M. N. Mamedov, et al.
Published: (2016-01-01) -
PHARMACOTHERAPY IN PATIENTS WITH ERECTILE DYSFUNCTION AND BENIGN PROSTATIC HYPERPLASIA IN THE ABSENCE OF RISK OF DISEASE PROGRESSION
by: A. A. Kamalov, et al.
Published: (2018-03-01) -
Phosphodiesterase type 5 inhibitors and erectile dysfunction
by: Catherine Whittaker
Published: (2010-06-01) -
MANAGEMENT OF ERECTILE DYSFUNCTION IN CARDIOVASCULAR PATIENTS WITH COMORBIDITIES: REVIEW OF THE TRIALS ON CONTINUING THERAPY WITH PHOSPHODIESTERASE-5 MEDICATIONS
by: G. G. Sharvadze, et al.
Published: (2018-06-01)